4//SEC Filing
Auster Martin 4
Accession 0001209191-23-025876
CIK 0001851194other
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 4:55 PM ET
Size
13.6 KB
Accession
0001209191-23-025876
Insider Transaction Report
Form 4
Auster Martin
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-04-25$38.76/sh−4,262$165,175→ 52,639 total - Sale
Common Stock
2023-04-25$39.23/sh−4,990$195,753→ 47,649 total - Exercise/Conversion
Common Stock
2023-04-25$3.45/sh+28,000$96,600→ 75,649 total - Sale
Common Stock
2023-04-25$37.55/sh−18,748$704,062→ 56,901 total - Exercise/Conversion
Stock Option (right to buy)
2023-04-25−28,000→ 275,184 totalExercise: $3.45Exp: 2031-05-06→ Common Stock (28,000 underlying)
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2022.
- [F2]Represents the weighted average share price of an aggregate total of 18,748 shares sold in the price range of $37.05 to $38.035. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average share price of an aggregate total of 4,262 shares sold in the price range of $38.055 to $39.055. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]Represents the weighted average share price of an aggregate total of 4,990 shares sold in the price range of $39.06 to $39.8098. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]Option granted under pursuant to the Issuer's 2019 Equity Incentive Plan, as amended (the "2019 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined 2019 Plan) through each applicable date, one third (1/3rd) of the shares subject to the options shall vest on the one year anniversary of the Vesting Commencement date, and, thereafter, one twenty-fourth (1/24th) of the remaining shares subject to the option shall vest each month on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean May 3, 2021.
Documents
Issuer
Ventyx Biosciences, Inc.
CIK 0001851194
Entity typeother
Related Parties
1- filerCIK 0001875786
Filing Metadata
- Form type
- 4
- Filed
- Apr 26, 8:00 PM ET
- Accepted
- Apr 27, 4:55 PM ET
- Size
- 13.6 KB